Search Results

There are 5877 results for: content related to: American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  4. You have full text access to this OnlineOpen article
    Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two–Week Randomized, Double-Blind, Placebo-Controlled Study

    Arthritis & Rheumatology

    Volume 69, Issue 5, May 2017, Pages: 1016–1027, William Stohl, Andreas Schwarting, Masato Okada, Morton Scheinberg, Andrea Doria, Anne E. Hammer, Christi Kleoudis, James Groark, Damon Bass, Norma Lynn Fox, David Roth and David Gordon

    Version of Record online : 7 APR 2017, DOI: 10.1002/art.40049

  5. You have free access to this content
    BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus

    IUBMB Life

    Volume 64, Issue 7, July 2012, Pages: 595–602, Kirsten Fairfax, Ian R. Mackay and Fabienne Mackay

    Version of Record online : 29 MAY 2012, DOI: 10.1002/iub.1046

  6. You have free access to this content
    Biologic agents in the treatment of glomerulonephritides

    Nephrology

    Volume 20, Issue 11, November 2015, Pages: 767–787, See Cheng Yeo and Adrian Liew

    Version of Record online : 7 OCT 2015, DOI: 10.1111/nep.12530

  7. You have free access to this content
    Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 64, Issue 7, July 2012, Pages: 2328–2337, William Stohl, Falk Hiepe, Kevin M. Latinis, Mathew Thomas, Morton A. Scheinberg, Ann Clarke, Cynthia Aranow, Frank R. Wellborne, Carlos Abud-Mendoza, Douglas R. Hough, Lilia Pineda, Thi-Sau Migone, Z. John Zhong, William W. Freimuth, W. Winn Chatham and on behalf of the BLISS-52 and BLISS-76 Study Groups

    Version of Record online : 26 JUN 2012, DOI: 10.1002/art.34400

  8. Belimumab: A BLyS-Specific Inhibitor for the Treatment of Systemic Lupus Erythematosus

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 143–149, G J Dennis

    Version of Record online : 30 NOV 2011, DOI: 10.1038/clpt.2011.290

  9. You have free access to this content
    Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 64, Issue 10, October 2012, Pages: 3364–3373, Joan T. Merrill, Ellen M. Ginzler, Daniel J. Wallace, James D. McKay, Jeffrey R. Lisse, Cynthia Aranow, Frank R. Wellborne, Michael Burnette, John Condemi, Z. John Zhong, Lilia Pineda, Jerry Klein, William W. Freimuth and on behalf of the LBSL02/99 Study Group

    Version of Record online : 27 SEP 2012, DOI: 10.1002/art.34564

  10. You have free access to this content
    Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus

    Arthritis Care & Research

    Volume 69, Issue 1, January 2017, Pages: 115–123, Luca Iaccarino, Silvano Bettio, Rossella Reggia, Margherita Zen, Micol Frassi, Laura Andreoli, Mariele Gatto, Silvia Piantoni, Linda Nalotto, Franco Franceschini, Maddalena Larosa, Micaela Fredi, Leonardo Punzi, Angela Tincani and Andrea Doria

    Version of Record online : 18 NOV 2016, DOI: 10.1002/acr.22971

  11. Belimumab therapy for systemic lupus erythematosus and potential treatment of rheumatoid arthritis

    Drug Development Research

    Volume 72, Issue 7, November 2011, Pages: 623–633, Changhai Ding, Ran Li, Jianhua Xu, Flavia Cicuttini and Graeme Jones

    Version of Record online : 23 NOV 2011, DOI: 10.1002/ddr.20472

  12. You have free access to this content
    Belimumab: targeted therapy for lupus

    International Journal of Rheumatic Diseases

    Volume 16, Issue 1, February 2013, Pages: 4–13, Preeta K. Chugh and Bhupinder S. Kalra

    Version of Record online : 19 OCT 2012, DOI: 10.1111/1756-185x.12002

  13. You have free access to this content
    A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 63, Issue 12, December 2011, Pages: 3918–3930, Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T. Merrill, W. Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William Freimuth, Ronald F. van Vollenhoven and BLISS-76 Study Group

    Version of Record online : 29 NOV 2011, DOI: 10.1002/art.30613

  14. You have free access to this content
    A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

    Arthritis Care & Research

    Volume 61, Issue 9, 15 September 2009, Pages: 1168–1178, Daniel J. Wallace, William Stohl, Richard A. Furie, Jeffrey R. Lisse, James D. McKay, Joan T. Merrill, Michelle A. Petri, Ellen M. Ginzler, W. Winn Chatham, W. Joseph McCune, Vivian Fernandez, Marc R. Chevrier, Z. John Zhong and William W. Freimuth

    Version of Record online : 27 AUG 2009, DOI: 10.1002/art.24699

  15. Biologic therapies in systemic lupus erythematosus

    International Journal of Rheumatic Diseases

    Volume 18, Issue 2, February 2015, Pages: 146–153, Christine B. Bernal, Leonid D. Zamora and Sandra V. Navarra

    Version of Record online : 17 APR 2015, DOI: 10.1111/1756-185X.12490

  16. Treatment of systemic lupus erythematosus: new advances in targeted therapy

    Annals of the New York Academy of Sciences

    Volume 1247, Issue 1, January 2012, Pages: 138–152, Mindy S. Lo and George C. Tsokos

    Version of Record online : 11 JAN 2012, DOI: 10.1111/j.1749-6632.2011.06263.x

  17. The pharmacokinetics and safety profiles of belimumab after single subcutaneous and intravenous doses in healthy Japanese volunteers

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 1, February 2014, Pages: 97–101, Y. Shida, N. Takahashi, T. Sakamoto, H. Ino, A. Endo and T. Hirama

    Version of Record online : 5 OCT 2013, DOI: 10.1111/jcpt.12101

  18. Current drugs in systemic lupus erythematosus

    Drug Development Research

    Volume 72, Issue 7, November 2011, Pages: 561–572, Yiyun Yu and Antonio La Cava

    Version of Record online : 23 NOV 2011, DOI: 10.1002/ddr.20466

  19. You have free access to this content
    Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study

    Arthritis & Rheumatism

    Volume 62, Issue 1, January 2010, Pages: 201–210, Annett M. Jacobi, Weiqing Huang, Tao Wang, William Freimuth, Inaki Sanz, Richard Furie, Meggan Mackay, Cynthia Aranow, Betty Diamond and Anne Davidson

    Version of Record online : 28 DEC 2009, DOI: 10.1002/art.27189

  20. Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus

    The Journal of Clinical Pharmacology

    Volume 53, Issue 7, July 2013, Pages: 711–720, Herbert Struemper, Cecil Chen and Wendy Cai

    Version of Record online : 16 MAY 2013, DOI: 10.1002/jcph.104